Clinical trials: Hair Diseases
Dandruff, Folliculitis
Artificial Intelligence-based Prescription of Personalized Scalp Cosmetics
The investigators aimed to evaluate whether they can be improved by an AI-based personalized prescription of scalp cosmetics.
- Trial name
- NCT06052241
- Where
- South Korea
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Seoul National University Bundang Hospital
Hair Thinning, Hair Shedding
A Clinical Trial to Examine the Efficacy of a Dietary Supplement to Improve the Health and Appearance of Hair.
This study evaluates the efficacy of Scale Media's HLV Clinical Formula Hair Vitamins on the health and appearance of hair, focusing on growth, volume, dullness, overall health, hair shedding, fullness, and strength.
- Trial name
- NCT06515496
- Testing
- Scale HLV Clinical Formula Hair Vitamins
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- Scale Media Inc
Alopecia Areata
Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
The main purpose of this study is to measure the efficacy of farudodstat compared to placebo at Week 12 from the treatment start, in adult participants with Alopecia Areata (AA) with 30% or greater scalp hair loss.
- Trial name
- FAST-AA (NCT05865041)
- Testing
- Farudodstat
- Where
- 19 sites in United States
- Volunteers
- 60 people
- Sponsor
- ASLAN Pharmaceuticals
Stress, Psychological, Father-Child Relations
Hair Cortisol as Marker of Chronic Stress in Preterm and Term Fathers - Fathair-study
The goal of this observational study is to compare the paternal hair cortisol as a marker for chronic stress in prematurely born children to maturely born children.
- Conditions
- Stress, Psychological, Father-Child Relations, Premature Birth
- Trial name
- NCT05969431
- Testing
- measurement of cortisol level
- Where
- Germany
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- University of Cologne
Alopecia Areata
Excimer Light for Alopecia Areata
Alopecia Areata (AA) is a chronic autoimmune inflammatory disease causing nonscarring hair loss. Many treatment modalities have been found to be helpful in AA, however, none on them cure the disease.
- Trial name
- NCT01802177
- Testing
- UVB excimer light
- Where
- Canada
- Volunteers
- 18 people
- Sponsor
- University of British Columbia
Female Pattern Hair Loss, Androgenetic Alopecia
Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil
5% topical minoxidil is the maximum dosage approved by the US FDA for the treatment of female pattern hair loss. While topical minoxidil exhibits a good safety profile, the efficacy in the overall population is relatively low…
- Trial name
- NCT02486848
- Testing
- 5% Topical Minoxidil Solution, 15% Topical Minoxidil Solution
- Where
- Italy
- Sponsor
- Maja Kovacevic, MD
Systolic Heart Failure
Hair Cortisol and Testosterone in Heart Failure
The purpose of this study is to determine whether hair cortisol and testosterone levels correlate with heart failure status in patient with chronic congestive heart failure.
- Trial name
- NCT01139697
- Testing
- Hair sampling
- Where
- Israel
- Volunteers
- 46 people
- Sponsor
- Meir Medical Center
Hair Thinning
Viviscal Extra-Strength Formulation To Promote Hair Growth And Decrease Shedding In Women With Thinning Hair
The Viviscal Extra-Strength formulation is an oral food/dietary supplement specifically designed to promote hair growth for women suffering from temporary thinning hair.
- Trial name
- NCT02297360
- Testing
- Viviscal Extra-Strength Supplement
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Ablon Skin Institute Research Center
Androgenetic Alopecia
Assessment of Dutasteride Topical Solution in Male Androgenetic Alopecia
This is a randomized, open-label phase 1/2a study designed to evaluate the pharmacokinetics, pharmacodynamics, and safety of AD-303A (topical formulation) and AD-3031 in male patients with androgenetic alopecia.
- Trial name
- NCT07490327
- Testing
- AD-303A, AD-3031
- Where
- South Korea
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Moogene Medi Co., Ltd
Alopecia Areata
Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areata
Methodology: The 70 patients of age 20 to 50 years presented to the out-patient department of CMH Abbottabad suffering from alopecia areata were enrolled. The non-probability consecutive sampling technique was used.
- Trial name
- NCT05885269
- Testing
- Group A applied topical Clobetasol Propionate, Group B applied topical Tacrolimus
- Where
- Pakistan
- Volunteers
- 70 people
- Sponsor
- Combined Military Hospital Abbottabad
Alopecia Areata
Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females
The purpose of this study is to determine whether the Hair Loss Prevention Lotion named MEXIS, M.P.A.F., M6S PATENT is effective in the treatment of Alopecia Areata.
- Trial name
- MEXISAREATA (NCT02604888)
- Testing
- MEXIS/M6S Patent - lotion against alopecia
- Where
- Greece
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Mexis George
Androgenic Alopecia
Condensed Nanofat Grafting for Treatment of Androgenetic Alopecia
Nowadays, multiple treatment modalities have been applied clinically to treat androgenic alopecia, such as Follicular unit transplantation(FUT), finasteride, platelet-rich plasma injection(PRP), etc.
- Trial name
- NCT03506503
- Testing
- Nanofat grafting
- Where
- China
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- Jinan University Guangzhou
Central Centrifugal Cicatricial Alopecia (CCCA)
Study to Determine Effect of Gentle Wounding to Stimulate Hair Follicle Neogenesis
The investigators have extensive evidence in mouse that wounding leads to the generation of new hair follicles in the skin. This can be an important new therapy for patients with scarring, but especially those with alopecia.
- Trial name
- NCT03491267
- Testing
- Retinoic acid, Laser
- Where
- United States
- Volunteers
- 24 people
- Sponsor
- Johns Hopkins University
Non-Segmental Vitiligo (NSV), Alopecia Areata
A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
This study is to assess the burden of disease in adolescent and adult participants with moderate or severe alopecia areata (AA), non-segmental vitiligo (NSV), or moderate to severe hidradenitis suppurativa (HS) in a large global…
- Conditions
- Non-Segmental Vitiligo (NSV), Alopecia Areata, Hidradenitis Suppurativa
- Trial name
- MEASUREAAVitHS (NCT07136467)
- Where
- 116 sites in Argentina, Canada and 16 more
- Volunteers
- 2,795 people
- Sponsor
- AbbVie
Hypertrichosis
A Prospective Multi-Center Study of a Novel Dual-Wavelength Laser for Hair Removal
To evaluate the safety and efficacy of the Cutera excel HR dual wavelength 755nm Alexandrite and 1064nm Nd:YAG laser for hair removal.
- Trial name
- NCT02536092
- Testing
- 755nm and 1064nm Nd:YAG laser
- Where
- 2 sites in Canada
- Volunteers
- healthy volunteers welcome
- Sponsor
- Cutera Inc.
Alopecia Areata
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
Prospective observational registry focusing on an adolescent cohort diagnosed with severe alopecia areata,receiving routine care from dermatology providers.
- Trial name
- NCT06562270
- Where
- United States
- Volunteers
- 1,500 people
- Sponsor
- CorEvitas
Cushing's Syndrome
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Participants in study C-1073-400 (NCT00569582) will be invited to participate in this extension study to examine the long term safety of mifepristone in the treatment of the signs and symptoms of endogenous Cushing's syndrome.
- Trial name
- NCT00936741
- Testing
- mifepristone
- Where
- 15 sites in United States
- Volunteers
- 30 people
- Sponsor
- Corcept Therapeutics
Alopecia Areata
Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)
Alopecia areata is a medical condition, in which the hair falls out in patches. The hair can fall out on the scalp or elsewhere on the face and body.
- Trial name
- NCT03359356
- Testing
- Dupilumab
- Where
- 2 sites in United States
- Volunteers
- 60 people
- Sponsor
- Icahn School of Medicine at Mount Sinai
Androgenetic Alopecia
Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss
The purpose of this study is to compare the efficacy of 3% Minoxidil lotion and 3% Minoxidil with 0.1% Finasteride lotion for 6 months in male pattern hair loss.
- Trial name
- NCT01391156
- Testing
- 3%Minoxidil lotion, 3% Minoxidil with 0.1% Finasteride lotion
- Where
- Thailand
- Volunteers
- 40 people
- Sponsor
- Mae Fah Luang University Hospital
Alopecia Areata
Topical Crisaborole in Patients with Alopecia Areata
The aim of this study is to determine whether topical crisaborole improves hair growth in alopecia areata.
- Trial name
- NCT04299503
- Testing
- Crisaborole Topical Ointment
- Where
- United States
- Sponsor
- Tufts Medical Center